ADC THERAPEUTICS SA shareholders Q2 2023

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 57 filers reported holding ADC THERAPEUTICS SA in Q2 2023. The put-call ratio across all filers is 37.00 and the average weighting 0.2%.

ADC THERAPEUTICS SA shareholders Q2 2023
NameSharesValueWeighting ↓
MILLENNIUM MANAGEMENT LLC 1,424,149$3,061,9200.00%
MARSHALL WACE, LLP 365,058$784,8750.00%
EVERGREEN CAPITAL MANAGEMENT LLC 11,000$23,6500.00%
Laurion Capital Management LP 120,881$259,8940.00%
Citadel Advisors 3,169,849$6,815,1750.00%
JPMORGAN CHASE & CO 2,760,081$5,934,1740.00%
MONETA GROUP INVESTMENT ADVISORS LLC 19,496$41,9160.00%
Qube Research & Technologies Ltd 69,876$150,2330.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 18,788$40,3940.00%
Verition Fund Management LLC 14,649$31,4950.00%
SIMPLEX TRADING, LLC 842$10.00%
AMERIPRISE FINANCIAL INC 89,526$192,4810.00%
Tower Research Capital LLC (TRC) 5,721$12,3000.00%
Cutler Group LLC / CA 1,400$30.00%
BARCLAYS PLC 314,925$6770.00%
ROYAL BANK OF CANADA 10,124$22,0000.00%
Focused Wealth Management, Inc 300$6450.00%
TD ASSET MANAGEMENT INC 74,690$160,5840.00%
JANE STREET GROUP, LLC 16,467$35,4040.00%
Cubist Systematic Strategies, LLC 27,437$58,9900.00%
External links

This page lists ADC THERAPEUTICS SA's shareholders in Q2 2023. To view ADC THERAPEUTICS SA's shareholder history, click here.